{"id":70,"date":"2018-10-05T17:23:21","date_gmt":"2018-10-05T17:23:21","guid":{"rendered":"https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/?p=70"},"modified":"2018-10-05T17:23:21","modified_gmt":"2018-10-05T17:23:21","slug":"urology-resident-hailiu-yang-md-presents-poster-at-ma-aua-annual-meeting","status":"publish","type":"post","link":"https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/2018\/10\/05\/urology-resident-hailiu-yang-md-presents-poster-at-ma-aua-annual-meeting\/","title":{"rendered":"Urology Resident Hailiu Yang, MD, Presents Poster at MA-AUA Annual Meeting"},"content":{"rendered":"<div id=\"attachment_73\" style=\"width: 2026px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-73\" class=\"wp-image-73 size-full\" src=\"https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/files\/2018\/10\/10-5-18-Dr-Yang-Poster-at-MAAUA18-3.jpg\" alt=\"\" width=\"2016\" height=\"1512\" srcset=\"https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/files\/2018\/10\/10-5-18-Dr-Yang-Poster-at-MAAUA18-3.jpg 2016w, https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/files\/2018\/10\/10-5-18-Dr-Yang-Poster-at-MAAUA18-3-300x225.jpg 300w, https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/files\/2018\/10\/10-5-18-Dr-Yang-Poster-at-MAAUA18-3-768x576.jpg 768w, https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/files\/2018\/10\/10-5-18-Dr-Yang-Poster-at-MAAUA18-3-1024x768.jpg 1024w\" sizes=\"auto, (max-width: 2016px) 100vw, 2016px\" \/><p id=\"caption-attachment-73\" class=\"wp-caption-text\">Dr. Hailiu Yang(right) with Jeffrey Tomaszewski and his poster, which was presented at the 2018 MAAUA Annual Meeting<\/p><\/div>\n<p>On October 5, 2018, PGY-4 Urology Resident\u00a0<a href=\"https:\/\/www.cooperhealth.edu\/residencies\/urology\/current-residents\">Hailiu Yang, MD, a PGY-4 urology resident<\/a>\u00a0presented a poster titled &#8220;Our Initial Experience with the 4Kscore\u00ae and How It Changes Practice in an Academic Urology Practice&#8221;. Dr. Yang&#8217;s presentation took place in Washington, DC during the annual meeting of the Mid-Atlantic Section of\u00a0 the American Urological Association. Congratulations, Dr. Yang!<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-72 size-full\" src=\"https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/files\/2018\/10\/10-5-18-Dr-Yang-Poster-at-MAAUA18-2.jpg\" alt=\"\" width=\"2016\" height=\"1512\" srcset=\"https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/files\/2018\/10\/10-5-18-Dr-Yang-Poster-at-MAAUA18-2.jpg 2016w, https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/files\/2018\/10\/10-5-18-Dr-Yang-Poster-at-MAAUA18-2-300x225.jpg 300w, https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/files\/2018\/10\/10-5-18-Dr-Yang-Poster-at-MAAUA18-2-768x576.jpg 768w, https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/files\/2018\/10\/10-5-18-Dr-Yang-Poster-at-MAAUA18-2-1024x768.jpg 1024w\" sizes=\"auto, (max-width: 2016px) 100vw, 2016px\" \/> <img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-71 size-full\" src=\"https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/files\/2018\/10\/10-5-18-Dr-Yang-Poster-at-MAAUA18-1.jpg\" alt=\"\" width=\"2016\" height=\"1512\" srcset=\"https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/files\/2018\/10\/10-5-18-Dr-Yang-Poster-at-MAAUA18-1.jpg 2016w, https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/files\/2018\/10\/10-5-18-Dr-Yang-Poster-at-MAAUA18-1-300x225.jpg 300w, https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/files\/2018\/10\/10-5-18-Dr-Yang-Poster-at-MAAUA18-1-768x576.jpg 768w, https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/files\/2018\/10\/10-5-18-Dr-Yang-Poster-at-MAAUA18-1-1024x768.jpg 1024w\" sizes=\"auto, (max-width: 2016px) 100vw, 2016px\" \/><\/p>\n<hr \/>\n<p><strong>MP3-08 &#8211; Our Initial Experience with the 4Kscore\u00ae and How It Changes Practice in an Academic Urology Practice<\/strong><\/p>\n<p class=\"role-title\">Poster Presenter(s): Hailiu Yang, MD, Resident Physician, Cooper University Hospital, Department of Surgery, Division of Urology<\/p>\n<p class=\"role-title\">Author(s):<\/p>\n<ul class=\"speakers-wrap\">\n<li class=\"speakerrow\">\n<div class=\"col-xs-3 photo-wrapper img-circle text-center no-photo relative\">Colin Sperling, Medical Student, Cooper Medical School of Rowan University<\/div>\n<\/li>\n<li class=\"speakerrow\">\n<div class=\"col-xs-3 photo-wrapper img-circle text-center no-photo relative\">Jeffrey Tomaszewski, MD, Assistant Professor; Director of Genitourinary Oncology, Cooper University Hospital Department of Surgery, Division of Urology<\/div>\n<\/li>\n<li class=\"speakerrow\">\n<div class=\"col-xs-3 photo-wrapper img-circle text-center no-photo relative\">Allen Seftel, MD, Chief, Division of Urology, Cooper University Hospital Department of Surgery, Division of Urology<\/p>\n<div class=\"col-xs-9 col-sm-10\">\n<div class=\"row\">\n<div class=\"col-xs-12 col-md-4\"><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/li>\n<\/ul>\n<p>Introduction &amp; Objective :<\/p>\n<p>Since the early 1990\u2019s, PSA screening has resulted in a 45% reduction in prostate cancer mortality. Despite this, there has been a lack of consensus among national policy panels about the optimal PSA threshold for biopsy recommendations\u00a0due to its poor specificity. Hence, there have been efforts to risk-stratify patients with abnormal PSA values to better guide biopsy decisions. The 4Kscore<sup>\u00ae<\/sup><sup>\u00a0<\/sup>is a novel test\u00a0which predicts the percentage risk of clinically significant prostate cancer (&gt;Gleason 3+4)\u00a0by assessing clinical information and four serum markers.\u00a0While there have been several validation studies regarding use of the 4Kscore, there is a paucity of data on how this test impacts clinical practice.\u00a0\u00a0In this abstract, we aimed to assess how the 4Kscore influenced biopsy related decisions in men evaluated in an academic urology practice.<\/p>\n<p>Methods:<\/p>\n<p>We retrospectively reviewed our electronic medical records for all patients who underwent a 4Kscore at our institution.\u00a0Since the implementation of the 4Kscore<sup>\u00ae<\/sup>\u00a0at our institution in 2015, all of our practitioners have implemented it using their own clinical judgement without restrictions.<\/p>\n<p>Results:<\/p>\n<p>Our analysis included a total of 308 men. The most common indications for 4Kscore testing were\u00a0elevated PSA (58%),\u00a0and abnormal\u00a0digital rectal exam (34%). The rate of transrectal ultrasound (TRUS) guided prostate biopsy within 6 months of 4Kscore testing was 142\/308 (46%). The mean 4Kscore was 26.4% in the biopsy group, while the mean 4Kscore in the non-biopsy group was 6% (p(Fig 1). Clinically significant disease was found in 36\/142 (25%) of biopsies. Treatment consisted of radical prostatectomy in 19\/36 (53%) patients, while 5\/19 (26%) opted for radiation therapy. Fifty patients that underwent TRUS biopsy had a PSA &gt;4 ng\/mL and 4Kscore &lt;7.5%, with a TRUS biopsy rate of 15\/54 (28%).<\/p>\n<p>Conclusions:<\/p>\n<p>Use of the 4Kscore test in conjunction with other clinical factors in an academic urology practice resulted in a reduction in the number of prostate biopsies by over 50%. A significant difference was seen in the 4Kscore of patients who underwent TRUS biopsy and those who did not.\u00a0\u00a0Based on our data, the 4Kscore is a beneficial adjunct screening tool to prevent unneeded prostate biopsies and diagnosis of men with clinically insignificant disease.<\/p>\n<hr \/>\n\n<div class=\"twitter-share\"><a href=\"https:\/\/twitter.com\/intent\/tweet?via=CooperGME\" class=\"twitter-share-button\">Tweet<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>On October 5, 2018, PGY-4 Urology Resident\u00a0Hailiu Yang, MD, a PGY-4 urology resident\u00a0presented a poster titled &#8220;Our Initial Experience with the 4Kscore\u00ae and How It Changes Practice in an Academic Urology Practice&#8221;. Dr. Yang&#8217;s presentation took place in Washington, DC during the annual meeting of the Mid-Atlantic Section of\u00a0 the American Urological Association. Congratulations, Dr. [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[6,4],"tags":[],"class_list":{"0":"post-70","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-papers-and-presentations","7":"category-resident-news","8":"entry"},"_links":{"self":[{"href":"https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/wp-json\/wp\/v2\/posts\/70","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/wp-json\/wp\/v2\/comments?post=70"}],"version-history":[{"count":1,"href":"https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/wp-json\/wp\/v2\/posts\/70\/revisions"}],"predecessor-version":[{"id":74,"href":"https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/wp-json\/wp\/v2\/posts\/70\/revisions\/74"}],"wp:attachment":[{"href":"https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/wp-json\/wp\/v2\/media?parent=70"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/wp-json\/wp\/v2\/categories?post=70"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.cooperhealth.org\/lifeatthecoop\/wp-json\/wp\/v2\/tags?post=70"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}